Roche Insulin Delivery Systems announces recall of ACCU-CHEK® FlexLink Plus infusion sets

Links shared publicly online about this topic.

482
total visits

Roche Insulin Delivery Systems announces recall of ACCU-CHEK® FlexLink Plus infusion sets

Roche Insulin Delivery Systems announced today that it is notifying its customers and healthcare professionals about the recall of the ACCU-CHEK® FlexLink Plus infusion set, because of the potential for under delivery of insulin due to a kinked/bent cannula when inserting the ACCU-CHEK FlexLink Plus infusion set. If this remains unnoticed, this can result in under delivery leading to elevation of blood glucose levels.

View full resource at fda.gov

Tags: Insulin, Healthcare

Most Recently Shared on March 4, 2011 at 12:54 am By:

Diabetes Coaching

Roche Insulin Delivery Systems has announced a recall of its Accuâ€“Chek FlexLink Plus infusion set. This set may... http://fb.me/WAh9rfXk

1 year ago...

Retweet

Favorite

Also Shared By:

Nephrology News

Roche Diagnostics, DexCom Announce Research and Development Agreement | IVD Technology

ivdtechnology.com — “Roche Diagnostics, with its business unit Roche Diabetes Care, and DexCom Inc. have signed a research and development agreement. The goal of this agreement is to integrate DexCom’s next-generation continuous glucose monitoring (CGM) system with the next-generation of Accu-Chek insulin delivery systems targeted at the U.S. market. In the future, users of an Accu-Chek insulin pump in the U.S.” View full resource at ivdtechnology.com

Most Recently Shared on November 3, 2011 at 6:32 pm By:

IVD Technology Health Magazine

Roche Diagnostics, DexCom Announce Research and Development Agreement http://t.co/6O0w5B7m

6 months ago...

Retweet

Favorite